ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Aspen's US & Canadian Strategy according to their June 2016 Year End Presentation.
Looks like Benztropine is next Aspen product to be launched by ANI, most likely by the end of the month, if they are still on schedule.

USA
- Maximise the value of our IP
- Launch our own and through partnering
- Assessing our in market footprint
- Stand alone, partner, acquire or combination

- Launched HPC - formulary driven, incremental momentum as contracts are signed
- Ramp up in H2 2017
- Acquired Benztropine - anticipate October launch
- Anticipated 2017 pipeline launch of oncology ANDA
- Danaparoid 2018?
- Further IP opportunities under discussion

Canada
- Responsive to increased headcount and investment
- Expansion to continue